Global analysis of cancer cell responses to USP9X inhibition

ABSTRACT: HDX-MS experiment using selective USP9X inhibitors WEHI-092, FT709 with recombinant catalytic domain USP9X.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Philipp Schenk  

LAB HEAD: David Komander

PROVIDER: PXD062754 | Pride | 2026-04-09

REPOSITORIES: Pride